TB has been one of the most notorious of all condition, and India has done its best all the time to help it get eradicated. Have we won the war against it? Unfortunately, the answer is NO. What is happening then? We cannot say we have lost, because cases have come significantly down. Yet, some cases have come up where the medicine is of no use! Why? The bacteria has become drug resistance. 

But Wait! Do not worry, because the recent news about the MoFW has just give approval to one of the regimes. Let us know what it is. 

Health Ministry Approves a Shorter Regime for TB! 

What is this new approval about? 

The union government has come up with a new, shorter treatment for drug-resistant tuberculosis (TB) in India. This new treatment is called BPaLM, and it’s said to be more effective at getting rid of multi-drug-resistant tuberculosis (MDR-TB), according to the health ministry.

The BPaLM treatment includes a new drug called Pretomanid, which is combined with other TB-fighting drugs like Bedaquiline and Linezolid (sometimes with Moxifloxacin).

Pretomanid was approved earlier by the Central Drugs Standard Control Organisation (CDSCO) for use in India.

What is this  BPaLM treatment? 

You must be wondering what is this treatment that just got an approval. So here it is. BPaLM is a new treatment for people who have a tough kind of tuberculosis (TB) called multi-drug-resistant TB (MDR-TB). 

Normally, treating this kind of TB takes a long time and can be hard, but BPaLM is a shorter and better way to treat it.

The treatment includes a special new medicine called Pretomanid, which works together with other medicines like Bedaquiline and Linezolid to fight the TB germs. Sometimes, another medicine called Moxifloxacin is used too.

This new treatment gives people hope because it can help them get better faster from MDR-TB.

What do the numbers say about TB In India? 

You want to know what is going on? India has about 75,000 people who are dealing with drug-resistant TB, and they will now be able to use this shorter treatment called BPaLM, that is some good news, honestly! One of the great things about this new treatment is that it will also save money for both the health system and the patients.

The ministry also shared that India has the biggest TB lab network in the world. There are 7,767 places where they can do rapid molecular testing, and 87 labs where they test how the TB germs respond to different drugs. This makes it easier to diagnose and treat TB in the country.

Does it have high success rate? 

Anything related to health and pharma is believed on the success rate offered, and it should be also. It is important. 

As per the above approved regime, reports say that BPaLM regimen can cure drug-resistant TB in just six months with a high treatment success rate. 

A New Ray of Hope! 

In conclusion, the introduction of the BPaLM treatment in India is a big step forward in the fight against drug-resistant TB. Not only does it offer a faster and more effective way to treat patients, but it also reduces the cost for both the healthcare system and individuals. With India’s vast TB lab network, this new regimen can reach and help thousands of patients, bringing hope for a healthier future.